Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2025: USD 371.47 M

Fisher & Paykel Healthcare Corporation Limited EBITDA is USD 371.47 M for the year ending March 31, 2025, a 68.77% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2024 was USD 220.10 M, a -18.83% change year over year.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2023 was USD 271.17 M, a -35.35% change year over year.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2022 was USD 419.42 M, a -25.69% change year over year.
  • Fisher & Paykel Healthcare Corporation Limited EBITDA for the year ending March 31, 2021 was USD 564.42 M, a 117.48% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)